| 摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: claimed invention is aimed at compound in accordance with formula (R2R3)-B1-A1-c(A2-A3-A4-A5-A6-A7-A8-A9)-A10-A11-A12-A13-B2-B3-R1, which act as ligands for one or several melanocortin receptors, their pharmaceutically acceptable salts. ^ EFFECT: elaboration of method of peptide application and obtaining pharmaceutical compositions, which include said peptides. ^ 132 cl, 4 tbl, 4 ex |
